Capital Management Corp VA boosted its holdings in shares of Albemarle Corporation (NYSE:ALB) by 24.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 102,563 shares of the specialty chemicals company’s stock after acquiring an additional 20,279 shares during the period. Albemarle Corporation accounts for approximately 4.0% of Capital Management Corp VA’s investment portfolio, making the stock its 2nd biggest position. Capital Management Corp VA owned about 0.09% of Albemarle Corporation worth $13,980,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Thompson Davis & CO. Inc. grew its stake in Albemarle Corporation by 650.0% during the 3rd quarter. Thompson Davis & CO. Inc. now owns 750 shares of the specialty chemicals company’s stock valued at $102,000 after acquiring an additional 650 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in Albemarle Corporation by 2.1% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 968 shares of the specialty chemicals company’s stock valued at $102,000 after acquiring an additional 20 shares in the last quarter. Carroll Financial Associates Inc. grew its stake in Albemarle Corporation by 0.3% during the 2nd quarter. Carroll Financial Associates Inc. now owns 982 shares of the specialty chemicals company’s stock valued at $103,000 after acquiring an additional 3 shares in the last quarter. Highlander Capital Management LLC purchased a new stake in Albemarle Corporation during the 2nd quarter valued at about $106,000. Finally, Smithfield Trust Co. grew its stake in Albemarle Corporation by 16.1% during the 2nd quarter. Smithfield Trust Co. now owns 1,008 shares of the specialty chemicals company’s stock valued at $106,000 after acquiring an additional 140 shares in the last quarter. 83.82% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: “Capital Management Corp VA Increases Position in Albemarle Corporation (ALB)” was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.watchlistnews.com/capital-management-corp-va-increases-position-in-albemarle-corporation-alb/1683210.html.

Several research firms have recently weighed in on ALB. Robert W. Baird reissued a “hold” rating and issued a $135.00 price target on shares of Albemarle Corporation in a research note on Wednesday, November 1st. Zacks Investment Research raised shares of Albemarle Corporation from a “hold” rating to a “buy” rating and set a $157.00 price target for the company in a research note on Tuesday, October 17th. Goldman Sachs Group, Inc. (The) cut shares of Albemarle Corporation from a “buy” rating to a “neutral” rating and increased their price target for the company from $139.66 to $142.00 in a research note on Friday, October 6th. Royal Bank Of Canada reissued a “buy” rating and issued a $149.00 price target on shares of Albemarle Corporation in a research note on Wednesday, October 18th. Finally, Instinet reissued a “buy” rating and issued a $154.00 price target (up previously from $146.00) on shares of Albemarle Corporation in a research note on Friday, October 13th. Eight analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Albemarle Corporation has a consensus rating of “Buy” and a consensus price target of $125.45.

In other Albemarle Corporation news, EVP Karen G. Narwold sold 11,500 shares of the stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $115.95, for a total transaction of $1,333,425.00. Following the sale, the executive vice president now directly owns 36,620 shares in the company, valued at approximately $4,246,089. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Matthew Juneau sold 5,397 shares of the stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $115.77, for a total transaction of $624,810.69. Following the sale, the executive vice president now owns 360 shares in the company, valued at $41,677.20. The disclosure for this sale can be found here. 0.74% of the stock is owned by corporate insiders.

Albemarle Corporation (ALB) traded up $0.73 during trading on Monday, reaching $140.77. 243,466 shares of the company’s stock were exchanged, compared to its average volume of 1,195,093. The firm has a market cap of $15,470.60, a price-to-earnings ratio of 36.19, a PEG ratio of 2.17 and a beta of 1.72. Albemarle Corporation has a 12 month low of $76.32 and a 12 month high of $143.69. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.67 and a current ratio of 2.24.

Albemarle Corporation (NYSE:ALB) last released its earnings results on Monday, August 7th. The specialty chemicals company reported $1.13 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.11 by $0.02. The company had revenue of $737.25 million for the quarter, compared to analyst estimates of $735.50 million. Albemarle Corporation had a net margin of 31.49% and a return on equity of 11.59%. The firm’s quarterly revenue was up 10.1% on a year-over-year basis. During the same period in the prior year, the business earned $0.93 EPS. analysts predict that Albemarle Corporation will post 4.36 EPS for the current year.

Albemarle Corporation Profile

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Corporation (NYSE:ALB).

Institutional Ownership by Quarter for Albemarle Corporation (NYSE:ALB)

Receive News & Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.